MIRA
INFORM REPORT
|
Report Date : |
16.09.2011 |
IDENTIFICATION DETAILS
|
Name : |
TRANSASIA BIO-MEDICALS LIMITED |
|
|
|
|
Formerly Known As : |
TRANSASIA BIO-MEDICALS PRIVATE LIMITED |
|
|
|
|
Registered Office : |
Transasia House, 8, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2010 |
|
|
|
|
Date of Incorporation : |
10.05.1985 |
|
|
|
|
Com. Reg. No.: |
11-36198 |
|
|
|
|
Capital Investment / Paid-up Capital : |
Rs.40.000
millions |
|
|
|
|
CIN No.: [Company
Identification No.] |
U33110MH1985PLC036198 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
MUMT00342G / MUMT09181E |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AAACT2038C |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company. |
|
|
|
|
Line of Business : |
Manufacturing, Marketing, Importers and Exporters of Instruments for measuring, Checking, Testing and Navigating. |
|
|
|
|
No. of Employees : |
350 Approximately |
RATING & COMMENTS
|
MIRA’s Rating : |
A (65) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
USD 12000000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established company having fine track. Financial position of the company appears to be sound. Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments. The concern can be considered good for normal business dealings at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – April 1, 2010
|
Country Name |
Previous Rating (31.12.2009) |
Current Rating (01.04.2010) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered Office : |
Transasia House, 8, |
|
Tel. No.: |
91-22-40309000 / 28575050 / 4040 |
|
Fax No.: |
91-22-28573030 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory 1 : |
47, Gelwad Falia, Dabhel, Opp. Somnath Bus Stop, Nani
Daman – 396 210, Daman, |
|
|
|
|
Factory 2 : |
B/11, GIDC, Ringanawada, Nani Daman – 396 210, Daman, |
|
|
|
|
Branches : |
·
606 / 607, Sethi Bhavan, 7, Tel. No.: 91-11-2573 2223
·
Flat No. 3/5, 1st Floor, Raghupriya
Apartments, 3, Tel. No.: 91-44-2826 0310
·
518, Kamalayaya Centre, 156 A, Lenin Sarani,
Kolkata – 700 013, West Tel. No.: 91-33-2536 1458
·
Ahmedabad, Tel. No.: 91-79-2658 9140 |
|
|
|
|
Regional Office : |
Located at : ·
·
·
· Jaipur · Kolkata · Mumbai · Pune · Ahmedabad ·
· Chennai ·
Bengalooru ·
|
DIRECTORS
As on 25.09.2010
|
Name : |
Mr. Suresh Hassanand Vazirani |
|
Designation : |
Chairman cum
Managing Director |
|
Address : |
Flat No. 3 C. Mittal
Paradise, Opposite Mittal Park, Off General Mhatre Marg, Juhu, Mumbai – 400
049, |
|
Date of Birth/Age : |
15.07.1949 |
|
Date of Appointment : |
10.05.1985 |
|
DIN No.: |
00122486 |
Other Directorship
|
S.No. |
CIN |
Name of the
Company |
Current
designation of the director |
Date of
appointment at current designation |
Original date of
appointment |
Date of
cessation |
Company Status |
Defaulting
status |
|
1 |
U33110MH1985PLC036198 |
Transasia Bio-Medicals
Limited |
Managing
director |
03-12-10 |
10-05-85 |
- |
Active |
NO |
|
2 |
U33110MH1988PLC047094 |
Transasia
Instruments Limited |
Managing
director |
20-04-88 |
20-04-88 |
- |
Active |
NO |
|
3 |
U33120MH1998PTC115943 |
Sysmex India Private
Limited |
Director |
23-07-98 |
23-07-98 |
12-12-08 |
Active |
NO |
|
4 |
U72100MH1999PTC120530 |
Mcsoft Infotech
Private Limited |
Managing
director |
25-06-99 |
25-06-99 |
- |
Active |
NO |
|
5 |
U05000MH2003PLC080999 |
Taipan Sea Foods
Limited |
Managing
director |
01-06-07 |
01-06-07 |
- |
Active |
NO |
|
6 |
U93090MH2009PTC190680 |
Sysmex Transasia
Services Private Limited |
Managing
director |
04-03-09 |
04-03-09 |
- |
Active |
NO |
|
Name : |
Mrs. Mala Suresh Vazirani |
|
Designation : |
Whole Time Director |
|
Address : |
Flat No. 3 C.
Mittal Paradise, Opposite Mittal Park, Off General Mhatre Marg, Juhu, Mumbai
– 400 049, |
|
Date of Birth/Age : |
13.08.1958 |
|
Date of Appointment : |
01.12.1986 |
|
DIN No.: |
00122711 |
Other Directorship
|
S.No. |
CIN |
Name of the
Company |
Current
designation of the director |
Date of
appointment at current designation |
Original date of
appointment |
Company Status |
Defaulting
status |
|
1 |
U33110MH1985PLC036198 |
Transasia
Bio-Medicals Limited |
Whole-time
director |
03-12-10 |
01-12-86 |
Active |
NO |
|
2 |
U33110MH1988PLC047094 |
Transasia
Instruments Limited |
Director |
20-04-88 |
20-04-88 |
Active |
NO |
|
3 |
U72100MH1999PTC120530 |
Mcsoft Infotech Private
Limited |
Director |
25-06-99 |
25-06-99 |
Active |
NO |
|
4 |
U05000MH2003PLC080999 |
Taipan Sea Foods
Limited |
Director |
01-06-07 |
01-06-07 |
Active |
NO |
|
Name : |
Mr. Francis
Matthew |
|
Designation : |
Director |
|
Address : |
209-D, Sheetal
Apartments, Seven Bunglows, Andheri (West), Mumbai - 400 053, |
|
Date of Birth/Age : |
10.07.1952 |
|
Date of Appointment : |
01.12.1986 |
|
DIN No.: |
00124796 |
Other Directorship
|
S.No. |
CIN |
Name of the Company |
Current
designation of the director |
Date of
appointment at current designation |
Original date of
appointment |
Date of
cessation |
Company Status |
Defaulting
status |
|
1 |
U33110MH1985PLC036198 |
Transasia
Bio-Medicals Limited |
Director |
01-12-86 |
01-12-86 |
- |
Active |
NO |
|
2 |
U63040MH1990PTC056406 |
Buenavista
Travels Private Limited |
Director |
03-05-90 |
03-05-90 |
- |
Active |
NO |
|
3 |
U33110MH1988PLC047094 |
Transasia
Instruments Limited |
Director |
21-01-01 |
21-01-01 |
- |
Active |
NO |
|
4 |
U26109WB1956PTC007912 |
SG Catering
Calcutta Private Limited |
Director |
17-05-07 |
17-05-07 |
08-04-10 |
Active |
NO |
|
5 |
U05000MH2003PLC080999 |
Taipan Sea Foods
Limited |
Director |
01-06-07 |
01-06-07 |
- |
Active |
NO |
KEY EXECUTIVES
|
Name : |
Mr. Ravindra Baburao Yevle |
|
Designation : |
Secretary |
|
Address : |
C/O. Transasia House 8, |
|
Date of Birth/Age : |
08.04.1954 |
|
Date of Appointment : |
26.04.2004 |
|
PAN No.: |
AAAPY2150K |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 25.09.2010
|
Names of Shareholders |
|
No. of Share |
|
Suresh Hassanand Vazirani |
|
3359225 |
|
Mala Suresh Vazirani |
|
640725 |
|
Nikhil Suresh Vazirani |
|
10 |
|
Vijay Parekh |
|
10 |
|
Francis Matthew |
|
10 |
|
Chandu P Sadarangani |
|
10 |
|
Sunil H Vazirani |
|
10 |
|
Total |
|
4000000 |
As on 25.09.2010
|
Equity Share Breakup |
|
Percentage of Holding |
|
Category |
|
|
|
Directors
or relatives of directors |
|
100.00 |
|
Total |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturing, Marketing, Importers and Exporters of Instruments for measuring, Checking, Testing and Navigating. |
||||||||
|
|
|
||||||||
|
Products : |
· Erba Chem-5 Plus – Semi Automatice Analyser · Erba Smart Lab · Erba Super Stat · Erba Instalyte – A complete range of ISE Electrolyte Analyzers · Erba XL – 600 – Automated Random Access Clinical Chemistr Analyser · Erba Coag Uno Coagulometer – A routine coagulation tests
|
GENERAL INFORMATION
|
No. of Employees : |
350 Approximately |
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Bankers : |
· Barclays Bank Plc 601/603, Ceejay House, Shivsagar Estate, Dr. Annie Besant Road, Worli, Mumbai – 400 018, Maharashtra, India ·
HDFC
Bank Limited
·
State Bank of MIDC Andheri (East) Branch, Plot
No. B-1, MIDC, · ABN Amro Bank NV
· ING Vysya Bank Limited
·
ICICI
Limited ·
IndusInd Bank Limited ·
Royal Bank of |
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Facilities : |
(The above facilities are secured by first paripassu charge in favour of RBS NV, HDFC Bank Limited, Barclays Bank PLC on immovable properties and entire current assets both present and future by way of hypothecation. (Further in favour of Barclays Bank an exclusive changes on units of Debts onented mutual funds having a value of atleast 100% of the SBLC value by ways of pledge.))
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Talati and Talati Chartered Accountant |
|
Address : |
Ambika Chambers, New Old High Court, Navrangpura,
Ahmedabad – 380 009, |
|
|
|
|
Subsidiaries : |
·
Erba Diagnostics · Erba Lachema S.R.O. · Zao Lachema International |
|
|
|
|
Other Related Parties : |
· Transasia Instruments Limited · Mcsoft Infotech Private Limited · Taipan Sea Foods Limited |
CAPITAL STRUCTURE
As on 25.09.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
4000000 |
Equity Shares |
Rs.10/- each |
Rs.40.000 millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
4000000 |
Equity Shares |
Rs.10/- each |
Rs.40.000 millions |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
40.000 |
40.000 |
20.000 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
3009.034 |
2291.761 |
1797.468 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
3049.034 |
2331.761 |
1817.468 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
257.662 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
8.556 |
3.814 |
33.461 |
|
|
TOTAL BORROWING |
266.218 |
3.814 |
33.461 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
3315.252 |
2335.575 |
1850.929 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
328.771 |
266.555 |
138.373 |
|
|
Capital work-in-progress |
137.339 |
5.925 |
0.014 |
|
|
|
|
|
|
|
|
INVESTMENT |
1607.213 |
1124.805 |
611.946 |
|
|
DEFERREX TAX ASSETS |
8.225 |
13.580 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
499.489
|
444.969 |
602.646 |
|
|
Sundry Debtors |
999.717
|
785.257 |
638.499 |
|
|
Cash & Bank Balances |
29.525
|
83.851 |
25.866 |
|
|
Other Current Assets |
3.992
|
1.409 |
0.000 |
|
|
Loans & Advances |
644.135
|
362.672 |
375.836 |
|
Total
Current Assets |
2176.858
|
1678.158 |
1642.847 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
384.589
|
377.360 |
234.878 |
|
|
Other Current Liabilities |
224.261
|
185.867 |
118.302 |
|
|
Provisions |
334.304
|
190.221 |
189.071 |
|
Total
Current Liabilities |
943.154
|
753.448 |
542.251 |
|
|
Net Current Assets |
1233.704
|
924.710 |
1100.596 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
3315.252 |
2335.575 |
1850.929 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
|
SALES |
|
|
|
|
|
|
|
Sales and Services (Net) |
2542.046 |
2136.536 |
1639.015 |
|
|
|
Other Income |
80.924 |
86.461 |
53.183 |
|
|
|
TOTAL (A) |
2622.970 |
2222.997 |
1692.198 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Raw Material Consumed |
435.228 |
410.727 |
0.000 |
|
|
|
Cost of Goods Sold / Consumed |
0.000 |
0.000 |
719.074 |
|
|
|
Purchase of Goods Traded |
662.225 |
494.347 |
0.000 |
|
|
|
Manufacturing Expenses |
47.867 |
43.714 |
0.000 |
|
|
|
Employee benefits |
324.518 |
259.866 |
197.704 |
|
|
|
Administrative Expenses |
209.281 |
182.411 |
107.335 |
|
|
|
Selling Expenses |
81.608 |
71.949 |
33.209 |
|
|
|
Research and Development Expenses |
76.889 |
70.231 |
59.306 |
|
|
|
Increase / (Decrease) in stock |
(137.308) |
31.013 |
0.000 |
|
|
|
TOTAL (B) |
1700.308 |
1564.258 |
1116.628 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
922.662 |
658.739 |
575.570 |
|
|
|
|
|
|
|
|
|
Less |
INTEREST AND
FINANCIAL COST (D) |
14.773 |
7.517 |
6.199 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
907.889 |
651.222 |
569.371 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
63.978 |
49.133 |
18.693 |
|
|
|
|
|
|
|
|
|
Less |
PRIOR YEAR
ADJUSTMENTS |
0.000 |
0.000 |
1.113 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
843.911 |
602.089 |
549.565 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
68.292 |
62.910 |
71.278 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
775.619 |
539.179 |
478.287 |
|
|
|
|
|
|
|
|
|
Less |
PRIOR YEAR
ADJUSTMENTS |
(0.152) |
0.124 |
0.000 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
2031.104 |
1604.468 |
1156.181 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Transfer to General Reserve |
77.562 |
53.921 |
0.000 |
|
|
|
Interim Dividend on Equity Shares |
50.000 |
50.000 |
30.000 |
|
|
|
Additional Tax on Dividend |
8.498 |
8.498 |
0.000 |
|
|
BALANCE CARRIED TO
THE B/S |
2670.815 |
2031.104 |
1604.468 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
297.800 |
335.100 |
294.110 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
648.080 |
459.610 |
460.200 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
193.90 |
163.50 |
242.50 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
PAT / Total Income |
(%) |
29.57
|
24.25 |
28.26 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
33.20
|
28.18 |
33.53 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
33.68
|
30.96 |
30.85 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.28
|
0.26 |
0.30 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
0.40
|
0.32 |
0.32 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.31
|
2.23 |
3.03 |
LOCAL AGENCY FURTHER INFORMATION
OPERATIONS AND PERFORMANCE REVIEW
The company has continued on its growth path
registering an increase in the overall turnover of 18.98% and 43.85% in the
Profit after tax. The company continues to hold for yet another year a major
market share in market segments like Haematology, Biochemistry (Routine
Chemistry Reagents) and Critical Care Electrolytes.
During the year company has successfully
established instrument unit at Baddi (Unit II) and commenced its commercial
operations. This will further strengthen the manufacturing capacity to cater
the increased demand of semi-auto bio chemistry analyzer.
FORM 8
|
This form is for |
Modification of charge |
|
Charge identification number of the modified |
10072790 |
|
Corporate identity number of the company |
U33110MH1985PLC036198 |
|
Name of the company |
TRANSASIA BIO-MEDICALS LIMITED |
|
Address of the registered office or of the principal place of business in |
Transasia House, 8, |
|
Type of charge |
·
Book debts ·
Movable property (not being pledge) ·
Floating charge |
|
Particular of charge holder |
HDFC Bank Limited HDFC Bank House, Senapati Bapat Marg, Lower Parel W, Mumbai – 400 013,
|
|
Nature of description of the instrument creating or modifying the
charge |
Supplemental letter of hypothecation of stocks, book-debts, machinery
and other current assets dated 9th July 2010. |
|
Date of instrument Creating the charge |
09.07.2010 |
|
Amount secured by the charge |
Rs.220.000 millions |
|
Brief particulars of the principal terms an conditions and extent and
operation of the charge |
Rate of interest As agreed to between M/S. Transasia Bio-Medicals Limited and M/S. HDFC
Bank Limited. Terms of repayment As agreed to between M/S. Transasia Bio-Medicals Limited and M/S. HDFC
Bank Limited. Margin As agreed to between M/S. Transasia Bio-Medicals Limited and M/S. HDFC
Bank Limited. Extent and operation of the charge First pari passu charge on entire current assets and movable plant and
machinery of the company, with ABN Amro Bank. |
|
Short particulars of the property charged |
Entire current assets and movable plant and machinery located at
company's factories at Chandivili, Daman And Baddi. |
|
Particulars of the present modification |
By the present modification the entire current assets and movable
fixed assets are now charged to cover the enhancement in working capital
limits from Rs.80.000 millions to Rs.220.000 millions. |
FIXED ASSETS
·
Land
·
Building
·
Plant and Machineries
·
Furniture and Fixtures
·
Motor Car
·
Computers
·
Electric and Office
Equipments
·
Instruments for Demo and
Placed at customers site
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.47.84 |
|
|
1 |
Rs.75.40 |
|
Euro |
1 |
Rs.65.68 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
8 |
|
PAID-UP CAPITAL |
1~10 |
7 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
8 |
|
--PROFITABILIRY |
1~10 |
8 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
8 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
65 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.